197 related articles for article (PubMed ID: 29072699)
1. CITED2 affects leukemic cell survival by interfering with p53 activation.
Mattes K; Berger G; Geugien M; Vellenga E; Schepers H
Cell Death Dis; 2017 Oct; 8(10):e3132. PubMed ID: 29072699
[TBL] [Abstract][Full Text] [Related]
2. CITED2-mediated human hematopoietic stem cell maintenance is critical for acute myeloid leukemia.
Korthuis PM; Berger G; Bakker B; Rozenveld-Geugien M; Jaques J; de Haan G; Schuringa JJ; Vellenga E; Schepers H
Leukemia; 2015 Mar; 29(3):625-35. PubMed ID: 25184385
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulators CITED2 and PU.1 cooperate in maintaining hematopoietic stem cells.
Mattes K; Geugien M; Korthuis PM; Brouwers-Vos AZ; Fehrmann RSN; Todorova TI; Steidl U; Vellenga E; Schepers H
Exp Hematol; 2019 May; 73():38-49.e7. PubMed ID: 30986495
[TBL] [Abstract][Full Text] [Related]
4. CITED2 silencing sensitizes cancer cells to cisplatin by inhibiting p53 trans-activation and chromatin relaxation on the ERCC1 DNA repair gene.
Liu YC; Chang PY; Chao CC
Nucleic Acids Res; 2015 Dec; 43(22):10760-81. PubMed ID: 26384430
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of CITED2 using short-hairpin RNA sensitizes cancer cells to cisplatin through stabilization of p53 and enhancement of p53-dependent apoptosis.
Wu ZZ; Sun NK; Chao CC
J Cell Physiol; 2011 Sep; 226(9):2415-28. PubMed ID: 21660965
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 inhibits cell division and increases apoptosis in gastric cancer.
Tang Z; He G; Xu J; Zhongfu L
J Surg Res; 2017 May; 211():1-7. PubMed ID: 28501104
[TBL] [Abstract][Full Text] [Related]
7. Cited2 modulates TGF-beta-mediated upregulation of MMP9.
Chou YT; Wang H; Chen Y; Danielpour D; Yang YC
Oncogene; 2006 Sep; 25(40):5547-60. PubMed ID: 16619037
[TBL] [Abstract][Full Text] [Related]
8. Cited2 is an essential regulator of adult hematopoietic stem cells.
Kranc KR; Schepers H; Rodrigues NP; Bamforth S; Villadsen E; Ferry H; Bouriez-Jones T; Sigvardsson M; Bhattacharya S; Jacobsen SE; Enver T
Cell Stem Cell; 2009 Dec; 5(6):659-65. PubMed ID: 19951693
[TBL] [Abstract][Full Text] [Related]
9. CITED2 controls the hypoxic signaling by snatching p300 from the two distinct activation domains of HIF-1α.
Yoon H; Lim JH; Cho CH; Huang LE; Park JW
Biochim Biophys Acta; 2011 Dec; 1813(12):2008-16. PubMed ID: 21925214
[TBL] [Abstract][Full Text] [Related]
10. High Glucose-Repressed CITED2 Expression Through miR-200b Triggers the Unfolded Protein Response and Endoplasmic Reticulum Stress.
Gu H; Yu J; Dong D; Zhou Q; Wang JY; Fang S; Yang P
Diabetes; 2016 Jan; 65(1):149-63. PubMed ID: 26450995
[TBL] [Abstract][Full Text] [Related]
11. Insulin Downregulates the Transcriptional Coregulator CITED2, an Inhibitor of Proangiogenic Function in Endothelial Cells.
Wang X; Lockhart SM; Rathjen T; Albadawi H; Sørensen D; O'Neill BT; Dwivedi N; Preil SR; Beck HC; Dunwoodie SL; Watkins MT; Rasmussen LM; Rask-Madsen C
Diabetes; 2016 Dec; 65(12):3680-3690. PubMed ID: 27561725
[TBL] [Abstract][Full Text] [Related]
12. CITED2 is activated in ulcerative colitis and induces p53-dependent apoptosis in response to butyric acid.
Yoshida T; Sekine T; Aisaki K; Mikami T; Kanno J; Okayasu I
J Gastroenterol; 2011 Mar; 46(3):339-49. PubMed ID: 21165656
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of autophagy as a treatment strategy for p53 wild-type acute myeloid leukemia.
Folkerts H; Hilgendorf S; Wierenga ATJ; Jaques J; Mulder AB; Coffer PJ; Schuringa JJ; Vellenga E
Cell Death Dis; 2017 Jul; 8(7):e2927. PubMed ID: 28703806
[TBL] [Abstract][Full Text] [Related]
14. Strain-induced mechanotransduction through primary cilia, extracellular ATP, purinergic calcium signaling, and ERK1/2 transactivates CITED2 and downregulates MMP-1 and MMP-13 gene expression in chondrocytes.
He Z; Leong DJ; Zhuo Z; Majeska RJ; Cardoso L; Spray DC; Goldring MB; Cobelli NJ; Sun HB
Osteoarthritis Cartilage; 2016 May; 24(5):892-901. PubMed ID: 26687824
[TBL] [Abstract][Full Text] [Related]
15. Aggressive acute myeloid leukemia in PU.1/p53 double-mutant mice.
Basova P; Pospisil V; Savvulidi F; Burda P; Vargova K; Stanek L; Dluhosova M; Kuzmova E; Jonasova A; Steidl U; Laslo P; Stopka T
Oncogene; 2014 Sep; 33(39):4735-45. PubMed ID: 24121269
[TBL] [Abstract][Full Text] [Related]
16. A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion.
Bai L; Merchant JL
FEBS Lett; 2007 Dec; 581(30):5904-10. PubMed ID: 18054336
[TBL] [Abstract][Full Text] [Related]
17. CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance.
Minemura H; Takagi K; Sato A; Takahashi H; Miki Y; Shibahara Y; Watanabe M; Ishida T; Sasano H; Suzuki T
Cancer Sci; 2016 Dec; 107(12):1898-1908. PubMed ID: 27627783
[TBL] [Abstract][Full Text] [Related]
18. Superior anti-tumor activity of the MDM2 antagonist idasanutlin and the Bcl-2 inhibitor venetoclax in p53 wild-type acute myeloid leukemia models.
Lehmann C; Friess T; Birzele F; Kiialainen A; Dangl M
J Hematol Oncol; 2016 Jun; 9(1):50. PubMed ID: 27353420
[TBL] [Abstract][Full Text] [Related]
19. CITED2 Restrains Proinflammatory Macrophage Activation and Response.
Kim GD; Das R; Rao X; Zhong J; Deiuliis JA; Ramirez-Bergeron DL; Rajagopalan S; Mahabeleshwar GH
Mol Cell Biol; 2018 Mar; 38(5):. PubMed ID: 29203644
[TBL] [Abstract][Full Text] [Related]
20. Pan-histone deacetylase inhibitor panobinostat sensitizes gastric cancer cells to anthracyclines via induction of CITED2.
Regel I; Merkl L; Friedrich T; Burgermeister E; Zimmermann W; Einwächter H; Herrmann K; Langer R; Röcken C; Hofheinz R; Schmid R; Ebert MP
Gastroenterology; 2012 Jul; 143(1):99-109.e10. PubMed ID: 22465428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
